James Fuson
Family Medicine · Greenville, SCNPI 1275571226
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $463 and has fallen 94.8% since, to $24 in 2025.
Across 80 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$252
- Novo Nordisk$194
- GSK$149
- Novartis$102
- Johnson & Johnson$90
- AstraZeneca$64
- plus $473 from 20 others
What the payments were for
- Food & beverage$1,324100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $252 |
| Novo Nordisk | 13 | $194 |
| GSK | 10 | $149 |
| Novartis | 5 | $102 |
| Johnson & Johnson | 6 | $90 |
| AstraZeneca | 5 | $64 |
| Pfizer | 3 | $41 |
| Currax Pharmaceuticals LLC | 3 | $40 |
| Antares Pharma, Inc. | 2 | $34 |
| Philips North America LLC | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Bayer | 2 | $29 |
| AbbVie | 1 | $27 |
| Dexcom, Inc. | 1 | $26 |
| Halozyme Inc | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Resmed Corp | 1 | $15 |
| Nalpropion Pharmaceuticals LLC | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$1,324 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 28 | $319 |
| Rosuvastatin Calcium | 14 | $180 |
| Atorvastatin Calcium | 25 | $171 |
| Amlodipine Besylate | 26 | $129 |
| Lisinopril | 11 | $98 |
| Omeprazole | 15 | $97 |
| Hydrochlorothiazide | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Greenville
- Steve HamberisGreenville$19K
- Richard LelandGreenville$19K
- Saria SaccocioGreenville$17K
- Eric FaileGreenville$15K
- Naveen BethiGreenville$14K
- James BridgemanGreenville$13K
- Angela SellGreenville$13K
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.